Video
Startup sniffs out mental health treatments using UQ drug delivery platform
A nasal spray technology that enables the delivery of drugs to treat mental health disorders will enter development for clinical use following the signing of a licence agreement with startup company InnarisBio, an atai Life Sciences company.
Topics
Related articles
Greater attention needed on community service workforce
Lack of job security and poor career progression are discouraging Australians from working in the community care sector, a report by UQ researchers has found.
26 November 2025
Nature versus nurture question addressed in landmark study
Genome sequencing has been used to determine how much genes influence human characteristics including height and weight, and susceptibility to diseases like Type 2 diabetes, in a study co-led by UQ researchers and collaborators at genomic technology company Illumina, Inc.
13 November 2025